Treatment

The partnership between The Southern Illinois University School of Medicine and Siteman Cancer Center investigates rural cancer disparities and ways to help educate, train, and implement effective strategies to reduce the disparities seen in rural communities.

As a co-investigator on the PCORI grant and PI of the subaward from Dartmouth College, Dr. Politi aims to support women of low socioeconomic status through early-stage breast cancer treatment decisions by providing patients with point-of-care decision aids.

Drs. Waters,  Hunleth, and colleagues will used a mixed methods research design to gain in-depth understanding of the psychological and social factors that shape the decision making process that caregivers use to care for their asthmatic children.  This project will provide evidence-based behavioral strategies to improve the lives of 6.2 million children who are affected by asthma.

 

This line of research strives to engage all members of the community throughout the research process to help navigate the healthcare process.

This project worked towards increasing and providing effective mammography screening for women in the St. Louis area.

Ying Liu, MD, PhD, assistant professor of surgery, has received a three-year, research scholar grant from the American Cancer Society to study disparities associated wtih ductal carcinoma in situ (DCIS).

Dr. Yin Cao received a Young Investigator Award from the National Comprehensive Cancer Network. This two-year award will support Dr. Cao in her work addressing colorectal cancer survival disparities among patients diagnosed under age 50 through integrating patients, treatment, and tumor molecular characteristics.

This project will address colorectal cancer mortality rates in rural Southern Illinois by  improving the screening process and follow-up for patients who have a positive fecal blood test (FOBT, FIT).

This project will develop tailored, patient-centered education materials to facilitate treatment decisions in patients with Hepatitis C infection and chronic kidney disease.

The MAPP study is a cohort study of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) from six sites across the United States. It was designed to better understand the natural history of these conditions and their underlying causes, taking a “whole-body” rather than a bladder- or prostate-specific approach.

This project will develop a preference-sensitive decision support tool for patients considering breast reconstruction after mastectomy. The tool will provide patient education, elicit patients’ preferences, and include personalized risk prediction to aid in the decision making process.

Dr. Yin Cao is leading efforts surround aspirin-based chemoprevention to inform future  multi-level interventions to improve the implementation of precision aspirin primary prevention strategies across systems, providers, and patients.

The PLUS Research Network is a multi-site network designed to develop the evidence base for future clinical trials to prevent the development and progression of lower urinary tract symptoms in women and girls. Current projects include a qualitative focus group study, the development of new instruments to measure bladder health, systematic reviews of the literature, and analyses of existing study data to better understand bladder health and factors that contribute to the development and progression of lower urinary tract symptoms.

Community-based participatory research (CBPR) helps give community members voice in academic research. These projects evaluated current and past CBPR projects to discovery future best practices.

The mission of Siteman Cancer Center’s Program for the Elimination of Cancer Disparities (PECaD) is to create a national model for eliminating local and regional disparities in cancer education, prevention and treatment. Through a community advisory committee and community partnerships, PECaD works with community representatives to find solutions that reduce disparities.

The Prostate Cancer Biorepository Network (PCBN) is a Department of Defense (DOD)/ Congressionally Directed Medical Research Program (CDMRP) bioresource that provides tissue and other biospecimens to all prostate cancer investigators.

The long-term goal of this collaboration between Dr. Drake and The St. Louis Mens Group Against Cancer is to be able to identify patients with increased risk for dying of prostate cancer while they are still treatable.

The PIE study is a cohort study of prostate cancer survivors who underwent prostate surgery at Washington University School of Medicine and Brigham & Women’s Hospital. These men were followed for one year after their surgery to better understand the natural history of treatment side effects, such as urinary incontinence and sexual dysfunction, and possible factors that influence the natural history of these side effects, such as physical activity and obesity.

A very dense breast on mammogram is one of the strongest risk factors for breast cancer, and many women in the United States have extremely dense breasts. There is, however, very limited knowledge on how to modify breast density to reduce breast cancer risk

This project, the Department of Defense Serum Repository Study of the Influence of Infections on Biomarkers of Prostate Pathology, is nested within the large population of men on active U.S. military duty with stored blood samples in the Department of Defense Serum Repository. The project examines the short- and longer-term influence of genitourinary and non-genitourinary infections on biomarkers of prostate pathology to inform the possible influence of infections on later prostate cancer risk.

This project will bring evidence-based decision tools to rural communities and attempt to support rural cancer patients’ participation in clinical trials.

The ColoCare Study follows a cohort of men and women who have been newly diagnosed with colorectal cancer (stages I-IV). This project's main interest is in quality-of-life and in rates of cancer recurrence and death.

Nonadherence can have significant negative health effects for the individual and contribute to increases in hospitalization, healthcare costs, and mortality. Adherence is a complex issue, but cost and affordability of medication is a common and critical barrier.The short-term objective is to identify how patients and healthcare providers approach affordability and adherence and use those data to refine and pilot test an intervention promoting patient-provider discussion about cost, affordability, and adherence. The long- term objective is to deliver interventions to reduce cost-related nonadherence.

Personalized health assessment tool that allows people to see their risk for common chronic conditions, such as diabetes, heart disease, stroke, and cancer risk.